Nutreco

ViAqua Therapeutics Ltd is an innovative biotechnology company based in Misgav, Israel, focused on developing therapeutics for the aquaculture industry. Founded in 2014, ViAqua is pioneering an orally administered particle-based platform that aims to prevent viral epidemics affecting aquatic species. The company utilizes a proprietary RNAi nanoparticle formulation that activates a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion, significantly enhancing the resistance of shrimp and other aquaculture species to viral diseases. With a management team possessing extensive experience in business development and industrial biotechnology, ViAqua Therapeutics is positioned to make a substantial impact on the health and sustainability of aquaculture practices.

BiomEdit is an innovation company focused on developing novel probiotics, microbiome-derived bioactives, and engineered microbial medicines to meet unmet needs in animal health. The company aims to address significant challenges in animal agriculture and food security by harnessing the potential of the microbiome. BiomEdit employs a unique platform that combines high-throughput sequencing and data analytics to efficiently discover and screen new probiotic species and bioactive molecules. These innovations can be engineered for enhanced stability and improved production of beneficial metabolites or immune-modulating proteins. The resulting probiotics and microbially-derived compounds represent advanced solutions designed to promote animal health while minimizing reliance on antibiotics.

Roslin Technologies is an ag-tech and food tech company focused on enhancing protein production through innovative biotechnologies. The company specializes in animal stem cell research, having developed perpetually self-renewing, pluripotent stem cells, which are pivotal for the advancement of cultivated meat products for consumers. Roslin's intellectual property and technological platforms are designed to supply these cell lines and related media formulations to the cultivated meat sector. Additionally, the company aims to leverage its stem cell technology to create cell therapies that address incurable diseases in animals, thereby supporting the meat industry in reducing costs and accelerating market entry.

Eruvaka Technologies Private Limited is a company specializing in the development and sale of on-farm diagnostic equipment for aquaculture farmers. Established in 2012 and based in Guntur, India, it focuses on integrating sensors and mobile connectivity to create affordable solutions for aquaculture monitoring and automation. One of its key products, the Eruvaka Floating Buoy, measures critical water parameters essential for shrimp growth and survival in real time. The equipment connects to a mobile application, allowing farmers to monitor pond data directly from their smartphones. By offering intelligent control of aerators and feeders, Eruvaka Technologies aims to help farmers reduce risks, lower production costs, and enhance yield while promoting sustainable practices in the aquaculture industry.

Stellapps Technologies Private Limited is an Internet of Things (IoT) company based in Bengaluru, India, focused on enhancing the dairy supply chain. Founded in 2011, Stellapps develops a range of innovative software applications designed to optimize dairy management. Key products include SmartMoo, an automated cow-milking application aimed at reducing waste, and MooOn, a wearable device for monitoring cattle health and herd management. The company also offers smartAMCU, an automatic milk collection unit controlled via an Android IoT device, and smartCC, a cloud-based solution for managing milk chilling centers. Stellapps provides consultancy services in fodder planning, milk collection, distribution, and marketing, utilizing advanced technologies such as big data, cloud computing, and data analytics. By leveraging these technologies, Stellapps aims to improve operational efficiency and profitability for dairy farmers and cooperatives.

Proteon Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative therapies for patients with renal and vascular diseases. Founded in 2001 and based in Waltham, Massachusetts, the company is known for its lead product candidate, vonapanitase, which is designed to improve hemodialysis vascular access outcomes. Vonapanitase, a recombinant human elastase, has successfully completed Phase II and Phase III clinical trials for patients suffering from chronic kidney disease and is currently being evaluated in a Phase I clinical trial for peripheral artery disease. The company aims to leverage its understanding of tissue remodeling to create effective treatments that address significant medical needs in these patient populations.

Proteon Pharmaceuticals Ltd. is a biotechnology company based in Lodz, Poland, founded in 2005. The company specializes in developing bacteriophage-based products aimed at enhancing animal and human health while promoting environmental sustainability. Proteon Pharmaceuticals employs precision biology to create solutions that protect the microbiome, significantly reducing the reliance on antibiotics and addressing the challenges posed by antimicrobial resistance. Their product pipeline includes innovative applications for poultry, aquaculture, and dairy sectors, focusing on improving performance, food safety, and preventing economically significant bacterial diseases. Additionally, the company offers contract services for high-throughput screening of chemical libraries, as well as ADME/Tox and immunotoxicity testing of therapeutic substances using in vitro cell cultures.

ENOUGH is a technology spin-out from the University of Strathclyde focused on developing and commercializing innovative patented technology for the production of mycoprotein, a meat alternative. The company integrates mycoprotein production within existing bio-refinery operations that also produce bio-ethanol and animal feed, promoting a sustainable circular economy. ENOUGH's mycoprotein-based products are designed to be environmentally friendly, utilizing less water and generating lower carbon dioxide emissions while employing a zero-waste fermentation process. This approach allows for the creation of food ingredients that contain all essential amino acids and are high in dietary fiber, providing consumers with a low-cost, sustainable protein option that serves as a meat substitute.

ViAqua Therapeutics Ltd is an innovative biotechnology company based in Misgav, Israel, focused on developing therapeutics for the aquaculture industry. Founded in 2014, ViAqua is pioneering an orally administered particle-based platform that aims to prevent viral epidemics affecting aquatic species. The company utilizes a proprietary RNAi nanoparticle formulation that activates a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion, significantly enhancing the resistance of shrimp and other aquaculture species to viral diseases. With a management team possessing extensive experience in business development and industrial biotechnology, ViAqua Therapeutics is positioned to make a substantial impact on the health and sustainability of aquaculture practices.

Mosa Meat B.V. is a food technology company based in Maastricht, the Netherlands, founded in 2013. The company specializes in the mass production of cultured meat by employing tissue engineering techniques. It harvests adult stem cells from the muscle tissue of living cows without harming the animals, allowing for the production of real meat, including hamburgers, with significantly reduced environmental impact. By cultivating meat from cells rather than raising and slaughtering livestock, Mosa Meat aims to promote a more sustainable global food system, addressing issues related to emissions, land and water use, and animal welfare.

West Coast Salmon plans to build and operate an industrial scale.

Mosa Meat B.V. is a food technology company based in Maastricht, the Netherlands, founded in 2013. The company specializes in the mass production of cultured meat by employing tissue engineering techniques. It harvests adult stem cells from the muscle tissue of living cows without harming the animals, allowing for the production of real meat, including hamburgers, with significantly reduced environmental impact. By cultivating meat from cells rather than raising and slaughtering livestock, Mosa Meat aims to promote a more sustainable global food system, addressing issues related to emissions, land and water use, and animal welfare.

BlueNalu, Inc. is a cellular aquaculture company based in San Diego, California, founded in 2017. The company specializes in processing and producing cell-based seafood products by culturing fish tissue from cells, thereby addressing the global demand for seafood while promoting sustainability and reducing overfishing. BlueNalu offers a range of healthy, safe, and high-quality seafood options that support the diversity of ocean ecosystems. Its innovative approach allows for the creation of fresh and frozen seafood products that are free from plastics, pathogens, toxins, and other contaminants, catering to restaurants and consumers seeking trusted seafood alternatives.

Mosa Meat B.V. is a food technology company based in Maastricht, the Netherlands, founded in 2013. The company specializes in the mass production of cultured meat by employing tissue engineering techniques. It harvests adult stem cells from the muscle tissue of living cows without harming the animals, allowing for the production of real meat, including hamburgers, with significantly reduced environmental impact. By cultivating meat from cells rather than raising and slaughtering livestock, Mosa Meat aims to promote a more sustainable global food system, addressing issues related to emissions, land and water use, and animal welfare.

ViAqua Therapeutics Ltd is an innovative biotechnology company based in Misgav, Israel, focused on developing therapeutics for the aquaculture industry. Founded in 2014, ViAqua is pioneering an orally administered particle-based platform that aims to prevent viral epidemics affecting aquatic species. The company utilizes a proprietary RNAi nanoparticle formulation that activates a cellular response to disable viral infections. This technology enables the delivery of coated nanoparticles through feed or immersion, significantly enhancing the resistance of shrimp and other aquaculture species to viral diseases. With a management team possessing extensive experience in business development and industrial biotechnology, ViAqua Therapeutics is positioned to make a substantial impact on the health and sustainability of aquaculture practices.

Eruvaka Technologies Private Limited is a company specializing in the development and sale of on-farm diagnostic equipment for aquaculture farmers. Established in 2012 and based in Guntur, India, it focuses on integrating sensors and mobile connectivity to create affordable solutions for aquaculture monitoring and automation. One of its key products, the Eruvaka Floating Buoy, measures critical water parameters essential for shrimp growth and survival in real time. The equipment connects to a mobile application, allowing farmers to monitor pond data directly from their smartphones. By offering intelligent control of aerators and feeders, Eruvaka Technologies aims to help farmers reduce risks, lower production costs, and enhance yield while promoting sustainable practices in the aquaculture industry.

Hi-Pro Feeds is a manufacturer and distributor of high-performance animal feed and nutrition services, based in Okotoks, Canada. Founded in 2012, the company produces a variety of animal nutrition products, including bulk feed, equine, dairy cattle, beef cattle, poultry, hog, grains, sheep, goat, and wildlife food. These products are designed to optimize health and nutrition for many animal species. Hi-Pro Feeds serves commercial livestock, dairy, and poultry producers through a network of dealers in both Canada and the United States. The company operates as a subsidiary of Nutreco N.V.

Micronutrients is a farming company focused on producing nutritional products, specifically animal feed ingredients. The company is dedicated to enhancing animal health and productivity through science-based research and development. By offering precision feed ingredients and trace minerals tailored for beef, dairy, poultry, and swine, Micronutrients aims to provide cost-effective solutions that improve animal performance, immunity, and overall well-being.